These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3862151)

  • 61. Borderline personality and the Rorschach test.
    Singer MT; Larson DG
    Arch Gen Psychiatry; 1981 Jun; 38(6):693-8. PubMed ID: 7247633
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of amphetamine on visuospatial working memory performance in schizophrenia spectrum personality disorder.
    Kirrane RM; Mitropoulou V; Nunn M; New AS; Harvey PD; Schopick F; Silverman J; Siever LJ
    Neuropsychopharmacology; 2000 Jan; 22(1):14-8. PubMed ID: 10633486
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognosis of the borderline disorders.
    Dahl AA
    Psychopathology; 1986; 19(1-2):68-79. PubMed ID: 3714942
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structured interviews and borderline personality disorder.
    Loranger AW; Oldham JM; Russakoff LM; Susman V
    Arch Gen Psychiatry; 1984 Jun; 41(6):565-8. PubMed ID: 6732418
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterizing affective instability in borderline personality disorder.
    Koenigsberg HW; Harvey PD; Mitropoulou V; Schmeidler J; New AS; Goodman M; Silverman JM; Serby M; Schopick F; Siever LJ
    Am J Psychiatry; 2002 May; 159(5):784-8. PubMed ID: 11986132
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Affective and behavioral features of DSM-III borderline personality disorder. Are they valid?
    Snyder S; Pitts WM; Pokorny AD
    Psychopathology; 1985; 18(1):3-10. PubMed ID: 4048371
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The amphetamine challenge test correlates with affective lability in healthy volunteers.
    Kavoussi RJ; Coccaro EF
    Psychiatry Res; 1993 Sep; 48(3):219-28. PubMed ID: 8272444
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Trauma, genes, and the neurobiology of personality disorders.
    Goodman M; New A; Siever L
    Ann N Y Acad Sci; 2004 Dec; 1032():104-16. PubMed ID: 15677398
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of affective instability in borderline personality disorder and bipolar disorder using a self-report measure.
    Reich DB; Zanarini MC; Hopwood CJ; Thomas KM; Fitzmaurice GM
    Personal Ment Health; 2014 May; 8(2):143-50. PubMed ID: 24700737
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hypothalamic-pituitary-adrenal axis functioning in borderline personality disorder: A meta-analysis.
    Drews E; Fertuck EA; Koenig J; Kaess M; Arntz A
    Neurosci Biobehav Rev; 2019 Jan; 96():316-334. PubMed ID: 30500331
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Orbitofrontal dysfunction related to depressive symptomatology in subjects with borderline personality disorder.
    Díaz-Marsá M; Carrasco JL; López-Ibor M; Moratti S; Montes A; Ortiz T; López-Ibor JJ
    J Affect Disord; 2011 Nov; 134(1-3):410-5. PubMed ID: 21641654
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diagnostic interview for borderline patients. A replication study.
    Soloff PH; Ulrich RF
    Arch Gen Psychiatry; 1981 Jun; 38(6):686-92. PubMed ID: 7247632
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hormonal responses to dextroamphetamine in depressed and normal adolescents.
    Waterman GS; Ryan ND; Puig-Antich J; Meyer V; Ambrosini PJ; Rabinovich H; Stull S; Novacenko H; Williamson DE; Nelson B
    J Am Acad Child Adolesc Psychiatry; 1991 May; 30(3):415-22. PubMed ID: 2055877
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Borderline manifestations in the Rorschachs of male transsexuals.
    Murray JF
    J Pers Assess; 1985 Oct; 49(5):454-66. PubMed ID: 4067791
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder.
    Bertsch K; Gamer M; Schmidt B; Schmidinger I; Walther S; Kästel T; Schnell K; Büchel C; Domes G; Herpertz SC
    Am J Psychiatry; 2013 Oct; 170(10):1169-77. PubMed ID: 23982273
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Borderline--a diagnostic entity?].
    Wöller W; Huppertz BJ
    Fortschr Neurol Psychiatr; 1984 Oct; 52(10):338-45. PubMed ID: 6500473
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dexamethasone suppression test in hospitalized depressed patients with borderline personality disorder.
    Beeber AR; Kline MD; Pies RW; Manring JM
    J Nerv Ment Dis; 1984 May; 172(5):301-3. PubMed ID: 6716096
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The influence of stress on social cognition in patients with borderline personality disorder.
    Deckers JW; Lobbestael J; van Wingen GA; Kessels RP; Arntz A; Egger JI
    Psychoneuroendocrinology; 2015 Feb; 52():119-29. PubMed ID: 25459898
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impulsivity and serotonergic function in compulsive personality disorder.
    Stein DJ; Trestman RL; Mitropoulou V; Coccaro EF; Hollander E; Siever LJ
    J Neuropsychiatry Clin Neurosci; 1996; 8(4):393-8. PubMed ID: 9116474
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Psychosis in borderline personality disorder.
    Jonas JM; Pope HG
    Psychiatr Dev; 1984; 2(4):295-308. PubMed ID: 6396640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.